The Cooper Companies Inc (COO)
88.84
-1.09
(-1.21%)
USD |
NASDAQ |
Apr 26, 16:00
88.84
0.00 (0.00%)
After-Hours: 18:24
Cooper Research and Development Expense (Quarterly): 39.50M for Jan. 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 39.50M |
| October 31, 2023 | 36.70M |
| July 31, 2023 | 36.50M |
| April 30, 2023 | 32.60M |
| January 31, 2023 | 31.60M |
| October 31, 2022 | 29.10M |
| July 31, 2022 | 28.70M |
| April 30, 2022 | 26.30M |
| January 31, 2022 | 26.20M |
| October 31, 2021 | 25.70M |
| July 31, 2021 | 24.80M |
| April 30, 2021 | 21.00M |
| January 31, 2021 | 21.40M |
| October 31, 2020 | 25.50M |
| July 31, 2020 | 21.80M |
| April 30, 2020 | 23.80M |
| January 31, 2020 | 22.20M |
| October 31, 2019 | 23.30M |
| July 31, 2019 | 21.50M |
| April 30, 2019 | 21.00M |
| January 31, 2019 | 21.00M |
| October 31, 2018 | 22.60M |
| July 31, 2018 | 22.50M |
| April 30, 2018 | 20.80M |
| January 31, 2018 | 18.80M |
| Date | Value |
|---|---|
| October 31, 2017 | 18.60M |
| July 31, 2017 | 17.50M |
| April 30, 2017 | 16.80M |
| January 31, 2017 | 16.30M |
| October 31, 2016 | 18.00M |
| July 31, 2016 | 15.90M |
| April 30, 2016 | 16.70M |
| January 31, 2016 | 14.80M |
| October 31, 2015 | 18.37M |
| July 31, 2015 | 18.30M |
| April 30, 2015 | 16.82M |
| January 31, 2015 | 16.11M |
| October 31, 2014 | 18.18M |
| July 31, 2014 | 16.07M |
| April 30, 2014 | 16.30M |
| January 31, 2014 | 15.71M |
| October 31, 2013 | 15.82M |
| July 31, 2013 | 14.86M |
| April 30, 2013 | 14.49M |
| January 31, 2013 | 13.65M |
| October 31, 2012 | 14.12M |
| July 31, 2012 | 13.16M |
| April 30, 2012 | 13.03M |
| January 31, 2012 | 11.42M |
| October 31, 2011 | 11.74M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
21.00M
Minimum
Apr 2019
39.50M
Maximum
Jan 2024
26.96M
Average
25.60M
Median
Research and Development Expense (Quarterly) Benchmarks
| Integer Holdings Corp | 13.26M |
| Anika Therapeutics Inc | 7.585M |
| Staar Surgical Co | 10.87M |
| OrthoPediatrics Corp | 2.747M |
| NexGel Inc | 0.013M |